James Leake

NPI: 1629498217
Total Payments
$110.89
2023 Payments
$91.08
Companies
3
Transactions
3
Medicare Patients
8,531
Medicare Billing
$2.9M

Payment Breakdown by Category

Food & Beverage$110.89 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $110.89 3 100.0%

Top Paying Companies

Company Total Records Latest Year
Telix Pharmaceuticals $60.04 1 $0 (2023)
Novartis Pharmaceuticals Corporation $31.04 1 $0 (2023)
Allergan Inc. $19.81 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $91.08 2 Telix Pharmaceuticals ($60.04)
2017 $19.81 1 Allergan Inc. ($19.81)

All Payment Transactions

3 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/23/2023 Telix Pharmaceuticals ILLUCCIX (Drug), ILLUCCIX Food and Beverage In-kind items and services $60.04 General
Category: PROSTATE CANCER THERAPY
02/24/2023 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $31.04 General
Category: Oncology
04/07/2017 Allergan Inc. ALLODERM (Device) Food and Beverage In-kind items and services $19.81 General
Category: PLASTIC SURGERY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 42 2,533 11,357 $5.2M $1.5M
2022 40 2,240 9,251 $2.4M $752,313
2021 41 2,624 10,819 $1.8M $445,540
2020 23 1,134 5,931 $721,461 $189,684
Total Patients
8,531
Total Services
37,358
Medicare Billing
$2.9M
Procedure Codes
175

All Medicare Procedures & Services

175 procedure records from CMS Medicare Utilization — Page 1 of 7

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
A9607 Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie Office 2023 16 3,200 $1.6M $619,924 39.0%
78815 Nuclear medicine study from skull base to mid-thigh with ct scan Office 2023 490 531 $1.2M $319,413 27.2%
A9596 Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie Office 2023 78 370 $1.0M $284,917 28.1%
A9595 Piflufolastat f-18, diagnostic, 1 millicurie Office 2023 15 120 $226,728 $61,811 27.3%
A9587 Gallium ga-68, dotatate, diagnostic, 0.1 millicurie Office 2023 18 390 $154,710 $44,688 28.9%
A9584 Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries Office 2023 18 18 $122,652 $35,143 28.7%
78816 Nuclear medicine study whole body with ct scan Office 2023 61 67 $104,785 $25,204 24.1%
74177 Ct scan of abdomen and pelvis with contrast Office 2023 145 145 $98,718 $18,677 18.9%
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Office 2023 137 139 $52,047 $12,457 23.9%
71260 Ct scan of chest with contrast Office 2023 134 136 $39,067 $7,682 19.7%
74177 Ct scan of abdomen and pelvis with contrast Facility 2023 87 87 $116,319 $5,761 5.0%
78803 Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging Office 2023 19 19 $23,388 $5,699 24.4%
78306 Nuclear medicine study of bone and/or joint whole body Office 2023 25 25 $18,468 $5,013 27.1%
78227 Nuclear medicine study of liver and bile duct system with use of drugs Office 2023 14 14 $13,617 $4,185 30.7%
78072 Nuclear medicine study of parathyroid with spect and ct scan Office 2023 12 12 $21,600 $3,991 18.5%
71275 Ct scan of blood vessels of chest with contrast Facility 2023 51 51 $67,116 $3,311 4.9%
74176 Ct scan of abdomen and pelvis without contrast Facility 2023 48 48 $61,344 $3,086 5.0%
78315 Nuclear medicine study of bone taken at different times Office 2023 11 11 $9,641 $3,018 31.3%
79101 Radioactive drug therapy through a vein Office 2023 19 21 $13,209 $2,557 19.4%
74176 Ct scan of abdomen and pelvis without contrast Office 2023 31 31 $16,170 $2,524 15.6%
71045 X-ray of chest, 1 view Facility 2023 357 371 $47,904 $2,471 5.2%
71250 Ct scan of chest without contrast Office 2023 34 34 $8,851 $1,969 22.2%
71250 Ct scan of chest without contrast Facility 2023 45 46 $28,635 $1,834 6.4%
74178 Ct scan of abdomen and pelvis before and after contrast Office 2023 11 11 $9,600 $1,815 18.9%
78582 Nuclear medicine study of lung ventilation and circulation Facility 2023 37 37 $25,678 $1,413 5.5%

About James Leake

James Leake is a Diagnostic Radiology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1629498217.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Leake has received a total of $110.89 in payments from pharmaceutical and medical device companies, with $91.08 received in 2023. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($110.89).

As a Medicare-enrolled provider, Leake has provided services to 8,531 Medicare beneficiaries, totaling 37,358 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 175 distinct procedure/service records.

Practice Information

  • Specialty Diagnostic Radiology
  • Location Austin, TX
  • Active Since 04/22/2014
  • Last Updated 05/07/2020
  • Taxonomy Code 2085R0202X
  • Entity Type Individual
  • NPI Number 1629498217

Products in Payments

  • ILLUCCIX (Drug) $60.04
  • PLUVICTO (Drug) $31.04
  • ALLODERM (Device) $19.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Diagnostic Radiology Doctors in Austin